Related content

Response to comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

By Nauck M.   Trautman M.   Brodows R.   Johns D.   Northrup J.   Kim D.  

Diabetologia, Vol. 50, Iss. 7, 2007-07 ,pp. : 1563-1564

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

By Home P.  

Diabetologia, Vol. 50, Iss. 7, 2007-07 ,pp. : 1561-1562

Springer Publishing Company

Access to resources Recommend Favorite

Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes - Influence of prior antidiabetic drug regimen

By Rendell M.S.   Glazer N.B.   Ye Z.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 4, 2003-07 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite

Spotlight on Insulin Aspart in Type 1 and 2 Diabetes Mellitus

By Chapman T.M.   Noble S.   Goa K.L.  

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 71-76

Adis International

Access to resources Recommend Favorite

The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study

By Moon Jun   Ha Kyoung   Yoon Ji   Lee Hyoung   Lee Hyun   Won Kyu  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 277-285

Springer Publishing Company

Access to resources Recommend Favorite